Literature DB >> 28833283

MicroRNA-337-3p controls hepatobiliary gene expression and transcriptional dynamics during hepatic cell differentiation.

Céline Demarez1, Claude Gérard1, Sabine Cordi1, Alexis Poncy1, Younes Achouri1,2, Nicolas Dauguet1, David A Rosa3, Patrick T Gunning3, Isabelle Manfroid4, Frédéric P Lemaigre1.   

Abstract

Transcriptional networks control the differentiation of the hepatocyte and cholangiocyte lineages from embryonic liver progenitor cells and their subsequent maturation to the adult phenotype. However, how relative levels of hepatocyte and cholangiocyte gene expression are determined during differentiation remains poorly understood. Here, we identify microRNA (miR)-337-3p as a regulator of liver development. miR-337-3p stimulates expression of cholangiocyte genes and represses hepatocyte genes in undifferentiated progenitor cells in vitro and in embryonic mouse livers. Beyond the stage of lineage segregation, miR-337-3p controls the transcriptional network dynamics of developing hepatocytes and balances both cholangiocyte populations that constitute the ductal plate. miR-337-3p requires Notch and transforming growth factor-β signaling and exerts a biphasic control on the hepatocyte transcription factor hepatocyte nuclear factor 4α by modulating its activation and repression. With the help of an experimentally validated mathematical model, we show that this biphasic control results from an incoherent feedforward loop between miR-337-3p and hepatocyte nuclear factor 4α.
CONCLUSION: Our results identify miR-337-3p as a regulator of liver development and highlight how tight quantitative control of hepatic cell differentiation is exerted through specific gene regulatory network motifs. (Hepatology 2018;67:313-327).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28833283     DOI: 10.1002/hep.29475

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2.

Authors:  Xue-Liang Zuo; Zhi-Qiang Chen; Jun-Feng Wang; Jin-Guo Wang; Lin-Hu Liang; Juan Cai
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.

Authors:  Liang Xia; Linlin Wu; Hailong Xia; Jing Bao; Qingsheng Li; Xiaowen Chen; Ruixiang Xia
Journal:  Cell Cycle       Date:  2019-06-18       Impact factor: 4.534

Review 3.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

4.  Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis.

Authors:  Wei Wu; Zijuan Wu; Yi Xia; Shuchao Qin; Yue Li; Jiazhu Wu; Jinhua Liang; Li Wang; Huayuan Zhu; Lei Fan; Jianxin Fu; Wei Xu; Hui Jin; Jianyong Li
Journal:  Aging (Albany NY)       Date:  2019-06-01       Impact factor: 5.682

5.  MIR337-3p Enhances Mycobacterial Pathogenicity Involving TLR4/MYD88 and STAT3 Signals, Impairing VDR Antimicrobial Response and Fast-Acting Immunity.

Authors:  Shanshan Liang; Guixian Huang; Tian Wu; Ying Peng; Xi Liu; Xuejiao Ji; Wei Sha; Feifei Wang; Ling Shen; Hongbo Shen
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

6.  Dynamics of hepatocyte-cholangiocyte cell-fate decisions during liver development and regeneration.

Authors:  Sarthak Sahoo; Ashutosh Mishra; Anna Mae Diehl; Mohit Kumar Jolly
Journal:  iScience       Date:  2022-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.